DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Hart TK, Blackburn MN, Brigham-Burke M. , et al.
Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.
Clin Exp Immunol 2002;
130 (01) 93-100
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.